Hubei Hongyuan Pharmaceutical Technology (301246.SZ) 48.0042 million restricted shares will be listed for trading on September 20th.
Hongyuan Pharmaceutical (301246.SZ) announcement, the number of shares released before the company's initial public offering is...
Hubei Hongyuan Pharmaceutical Technology (301246.SZ) announcement, the number of restricted shares lifted this time before the company's initial public offering was 48,004,200 shares, accounting for 12.00% of the total share capital after the company's issuance. The listing date is September 20, 2024 (Friday).
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
